Literature DB >> 21180566

Diagnosis and treatment of paroxysmal dyskinesias revisited.

Iris Unterberger1, Eugen Trinka.   

Abstract

Paroxysmal dyskinesias (PDs) are a rare group of hyperkinetic movement disorders mainly characterized by their episodic nature. Neurological examination may be entirely normal between the attacks. Three main types of PDs can be distinguished based on their precipitating events - (i) paroxysmal kinesigenic dyskinesias (PKD), (ii) paroxysmal non-kinesigenic dyskinesias (PNKD) and (iii) paroxysmal exercise-induced (exertion-induced) dyskinesias (PED). The diagnosis of PDs is based on their clinical presentation and precipitating events. Substantial progress has been made in the field of genetics and PDs. Treatment options mainly include anticonvulsants and benefit of treatment is depending on the type of PD. Most important differential diagnosis are non-epileptic psychogenic, non-epileptic organic and epileptic attack disorders, especially nocturnal frontal lobe epilepsy.

Entities:  

Keywords:  epilepsy; paroxysmal dyskinesia; paroxysmal exercise-induced (exertion-induced) dyskinesia; paroxysmal kinesigenic dyskinesia; paroxysmal non-kinesigenic dyskinesia

Year:  2008        PMID: 21180566      PMCID: PMC3002546          DOI: 10.1177/1756285608095119

Source DB:  PubMed          Journal:  Ther Adv Neurol Disord        ISSN: 1756-2856            Impact factor:   6.570


  57 in total

Review 1.  Classification of paroxysmal dyskinesias and ataxias.

Authors:  Joseph Jankovic; Meltem Demirkiran
Journal:  Adv Neurol       Date:  2002

2.  A gene for familial paroxysmal dyskinesia (FPD1) maps to chromosome 2q.

Authors:  G T Fouad; S Servidei; S Durcan; E Bertini; L J Ptácek
Journal:  Am J Hum Genet       Date:  1996-07       Impact factor: 11.025

3.  Neurotoxicity of methylglyoxal and 3-deoxyglucosone on cultured cortical neurons: synergism between glycation and oxidative stress, possibly involved in neurodegenerative diseases.

Authors:  S Kikuchi; K Shinpo; F Moriwaka; Z Makita; T Miyata; K Tashiro
Journal:  J Neurosci Res       Date:  1999-07-15       Impact factor: 4.164

4.  Paroxysmal kinesigenic choreoathetosis. An entity within the paroxysmal choreoathetosis syndrome. Description of 10 cases, including 1 autopsied.

Authors:  A Kertesz
Journal:  Neurology       Date:  1967-07       Impact factor: 9.910

5.  Presence of alanine-to-valine substitutions in myofibrillogenesis regulator 1 in paroxysmal nonkinesigenic dyskinesia: confirmation in 2 kindreds.

Authors:  Dong-Hui Chen; Mark Matsushita; Shirley Rainier; Brandon Meaney; Lisa Tisch; Abreham Feleke; John Wolff; Hillary Lipe; John Fink; Thomas D Bird; Wendy H Raskind
Journal:  Arch Neurol       Date:  2005-04

6.  Further localization of a gene for paroxysmal dystonic choreoathetosis to a 5-cM region on chromosome 2q34.

Authors:  W H Raskind; T Bolin; J Wolff; J Fink; M Matsushita; M Litt; H Lipe; T D Bird
Journal:  Hum Genet       Date:  1998-01       Impact factor: 4.132

7.  Hypnogenic paroxysmal dystonia: epileptic seizure or a new syndrome?

Authors:  E Lugaresi; F Cirignotta
Journal:  Sleep       Date:  1981       Impact factor: 5.849

8.  Topiramate therapy for paroxysmal kinesigenic choreoathetosis.

Authors:  Yuan-Gui Huang; Yun-Chun Chen; Fang Du; Rui Li; Ge-Lin Xu; Wen Jiang; Jing Huang
Journal:  Mov Disord       Date:  2005-01       Impact factor: 10.338

Review 9.  Paroxysmal dyskinesias.

Authors:  Jonathan W Mink
Journal:  Curr Opin Pediatr       Date:  2007-12       Impact factor: 2.856

10.  Paroxysmal dystonia as the initial manifestation of multiple sclerosis.

Authors:  J R Berger; W A Sheremata; E Melamed
Journal:  Arch Neurol       Date:  1984-07
View more
  10 in total

Review 1.  Mutational consequences of aberrant ion channels in neurological disorders.

Authors:  Dhiraj Kumar; Rashmi K Ambasta; Pravir Kumar
Journal:  J Membr Biol       Date:  2014-08-14       Impact factor: 1.843

2.  Paroxysmal Kinesigenic Dyskinesia as the Presenting and Only Manifestation of Multiple Sclerosis after Eighteen Months of Follow-Up.

Authors:  Marius Baguma; Michel Ossemann
Journal:  J Mov Disord       Date:  2017-03-24

3.  A case of mitochondrial cytopathy with exertion induced dystonia.

Authors:  Sadanandavalli Retnaswami Chandra; Thomas Gregor Issac
Journal:  J Pediatr Neurosci       Date:  2015 Jul-Sep

4.  Approach to exaggerated startle reflex: a case of hyperekplexia minor.

Authors:  Haris Hakeem; Ramsha Khurshid; Fowzia Siddiqui; Danish Ejaz Bhatti
Journal:  BMJ Case Rep       Date:  2020-04-23

5.  Pathological laughter associated with paroxysmal kinesigenic dyskinesia: A rare presentation of acute disseminated encephalomyelitis.

Authors:  Neera Chaudhry; Vinod Puri; Yogesh Patidar; Geeta A Khwaja
Journal:  Epilepsy Behav Case Rep       Date:  2012-11-13

6.  Electromyographic and Joint Kinematic Patterns in Runner's Dystonia.

Authors:  Omar F Ahmad; Pritha Ghosh; Christopher Stanley; Barbara Karp; Mark Hallett; Codrin Lungu; Katharine Alter
Journal:  Toxins (Basel)       Date:  2018-04-20       Impact factor: 4.546

Review 7.  KCNMA1-linked channelopathy.

Authors:  Cole S Bailey; Hans J Moldenhauer; Su Mi Park; Sotirios Keros; Andrea L Meredith
Journal:  J Gen Physiol       Date:  2019-08-19       Impact factor: 4.086

8.  Paroxysmal Kinesigenic Dyskinesia Presented Following Concussion.

Authors:  Norman Cottrill; Brian McCully; Mary Payne
Journal:  J Mov Disord       Date:  2018-12-19

9.  Paroxysmal head drops with ataxia-like symptoms presenting as Sandifer syndrome in a 3-year old girl.

Authors:  Abubakar Sharif; Lucinda Carr; Efstratios Saliakellis; Himadri Chakraborty
Journal:  BMJ Case Rep       Date:  2020-03-04

10.  Aberrant Sensory Gating of the Primary Somatosensory Cortex Contributes to the Motor Circuit Dysfunction in Paroxysmal Kinesigenic Dyskinesia.

Authors:  Yo-Tsen Liu; Yi-Chieh Chen; Shang-Yeong Kwan; Chien-Chen Chou; Hsiang-Yu Yu; Der-Jen Yen; Kwong-Kum Liao; Wei-Ta Chen; Yung-Yang Lin; Rou-Shayn Chen; Kang-Yang Jih; Shu-Fen Lu; Yu-Te Wu; Po-Shan Wang; Fu-Jung Hsiao
Journal:  Front Neurol       Date:  2018-10-15       Impact factor: 4.003

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.